NaviCam ProScan

Ankon Technologies co., ltd · DEN230027 · 2023-12-12

NaviCam ProScan is an AI-enabled medical device from Ankon Technologies co., ltd, listed by FDA (De Novo, DEN230027) with a decision date of 2023-12-12. Review panel: Gastroenterology-Urology.

FDA submission numberDEN230027
PathwayDe Novo
CompanyAnkon Technologies co., ltd
Review panel (specialty)Gastroenterology-Urology
FDA decision date2023-12-12
DecisionUnknown
Product codeQZF
ClassificationGastrointestinal Capsule Endoscopy Analysis Software Device
Device class2
Regulation number876.1540
Review time (calendar days)242
Applicant countryCN

Official FDA database record · FDA AI-enabled device list

All Gastroenterology-Urology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.